Nakajima, H.; Ishikawa, H.; Yamamoto, T.; Chiba, A.; Fukui, H.; Sako, K.; Fukumoto, M.; Mattonet, K.; Kwon, H.-B.; Hui, S. P.et al.; Dobreva, G. D.; Kikuchi, K.; Helker, C. S. M.; Stainier, D. Y. R.; Mochizuki, N.: Endoderm-derived islet1-expressing cells differentiate into endothelial cells to function as the vascular HSPC niche in zebrafish. DEVELOPMENTAL CELL 58 (3), pp. 224 - + (2023)
Kwon, H.-B.; Mackie I, D.; Bonnavion, R.; Le Mercier, A.; Helker, C. S. M.; Son, T.; Guenter, S.; Serafin, D. S.; Kim, K.-W.; Offermanns, S.et al.; Caron, K. M.; Stainier, D. Y. R.: The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE 3 (4), pp. 676 - 689 (2020)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).